| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Tevogen ("Tevogen Bio Holdings Inc." or "Company") (NASDAQ:TVGN), today announced an update on institutional ownership of the Company's outstanding common stock, as reported by institutional investment managers on Form 13F filed with the Securities and Exchange Commission (SEC).
As reported on March 31, 2025, institutional ownership of Tevogen common stock increased by 60% compared to the reported amount on December 31, 2024. The largest contributors to this growth were Vanguard and BlackRock, which together increased their holdings by 151%. Among the 51 institutional investment managers holding Tevogen stock as reported on March 31, 2025, 73% increased or maintained their positions. Notably, only one of the current institutional holders also held Tevogen stock during the same period in the prior year (March 31, 2024), reflecting a significant influx of new investors.
Posted In: TVGN
